Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Particle Size Analysis System

By Drug Discovery Trends Editor | March 22, 2010

Beckman Coulter LS 13 320Beckman Coulter, Inc., has extended the range of its LS 13 320 particle size analyzer to allow high-resolution, reproducible measurement of samples from 0.017 to 2000 µm.  The enhanced LS 13 320 also adds Rosin-Rammler and Folk & Ward Phi methods to its standard analytical capabilities.

The instrument’s Tornado Dry Powder Dispersing System keeps sample particles intact, allowing true measurement of the original samples.  Reproducibility is typically better than one percent.  These features combine with the extended size range to provide high-accuracy/high-resolution detection without the risk of missing either the largest or the smallest particles in a sample.

The LS 13 320 differs from other laser-based instruments by virtue of its wide dynamic size range, number of detectors and sample measurement options. Reverse Fourier optics incorporated in a patented fiber-optic spatial filter system optimize light scattering measurement. Beckman Coulter’s Polarization Intensity Differential Scattering (PIDS) technology furthers detection capabilities in pharmaceutical, plastics, food and beverage, and a variety of other applications.

Beckman Coulter


Filed Under: Drug Discovery

 

Related Articles Read More >

The FDA’s AI ambitions depend on better data practices
Researchers working in the clinical laboratory
Outpatient clinics are becoming critical Infrastructure for drug trials
SAS launches clinical trial analytics software built on its Viya cloud native analytics platform
Bayer’s Lynkuet approved by FDA for menopausal hot flashes
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE